Loading company details...
Beta
Latest Form 4 (Oct 5, 2026): Joseph Ronald Catapano (Chief Accounting Officer): Exercise/Conversion of 2,083 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Joseph Ronald Catapano, Chief Accounting Officer | Exercise/Conversion | 2,083 | n/a |
| Sep 14, 2026 | Charles Divita III, CHIEF EXECUTIVE OFFICER | Exercise/Conversion | 3,642 | n/a |
| Sep 3, 2026 | Carlos Nueno, President, International | Exercise/Conversion | 4,556 | n/a |
| Sep 3, 2026 | Adam C. Vandervoort, CHIEF LEGAL OFFICER, SECRETARY | Exercise/Conversion | 5,350 | n/a |
| Sep 3, 2026 | Kelly Bliss, President, U.S. Group Health | Exercise/Conversion | 4,859 | n/a |
| Sep 3, 2026 | Joseph Ronald Catapano, Chief Accounting Officer | Exercise/Conversion | 833 | n/a |
| Sep 1, 2026 | Michael F. Grasher, Chief Financial Officer | Grant/Award | 239,616 | n/a |
| Aug 4, 2026 | Mark Anquillare V | Grant/Award | 37,425 | n/a |
| Jul 6, 2026 | Kelly Bliss, President, U.S. Group Health | Sale | 2,500 | $23.8K |
| Jul 6, 2026 | Joseph Ronald Catapano, Chief Accounting Officer | Exercise/Conversion | 2,083 | n/a |